Dompe partners with SatRx - MarketLine Financial Deals

Dompe partners with SatRx

Dompe partners with SatRx - MarketLine Financial Deals
Dompe partners with SatRx
Published Jun 21, 2013
2 pages — Published Jun 21, 2013
Price US$ 20.00  |  Buy this Report Now

About This Report


Dompe S.p.A., an Italy-based biopharmaceutical company, has entered into an agreement with 'SatRx', LLC, a Russia-based biotechnology company, for the clinical development of Reparixin, a drug discovered by Dompe, to improve efficacy of liver transplantation.

Document ID
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author

Cite this Report

MarketLine Financial Deals. "Dompe partners with SatRx" Jun 21, 2013. Alacra Store. Jun 19, 2018. <>
MarketLine Financial Deals. (2013). Dompe partners with SatRx Jun 21, 2013. New York, NY: Alacra Store. Retrieved Jun 19, 2018 from <>
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.